The A 3 antagonist VUF5574 increased the mean amplitude of both the a-wave (65.8±8.0 µV to 139.5±29.3 µV; p = 0.046) and the b-wave of dark adapted eyes (223.7±20.3 µV to 312 µV±38.7 µV; p = 0.037).
A 3 andverkarinn jók meðal spennuvídd bæði a-bylgju (65.8±8.0 µV í 139.5±29.3 µV; p = 0.046) og rökkursaðlögu b-bylgju (223.7±20.3 µV í 312 µV±38.7 µV; p = 0.037).